Institutional investors purchased a net $3.5 million shares of GSK during the quarter ended September 2016 and now own 8.89% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GRANTHAM, MAYO, VAN OTTERLOO & C... Bought 1.4 Million shares of GlaxoSmithKline
MARSHALL WACE LLP Bought 784.4 Thousand shares of GlaxoSmithKline